Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 750 | 0 | 12,600 | 33,473 | 16,526 |
| Gross Profit | 750 | N/A | 12,600 | 33,473 | 16,526 |
| Operating Expenses | 112,787 | 136,714 | 92,127 | 76,520 | 64,448 |
| Operating Income | -112,037 | -136,714 | -79,527 | -43,047 | -47,922 |
| Interest Expense | 203 | 160 | 221 | 290 | 276 |
| Other Income | 600 | 4,439 | 5,476 | 5,700 | 2,942 |
| Pre-tax Income | -111,640 | -132,435 | -74,272 | -37,637 | -45,256 |
| Income Tax | -93 | -89 | N/A | N/A | N/A |
| Net Income Continuous | -111,547 | -132,346 | -74,272 | -37,637 | -45,256 |
| Net Income | $-111,547 | $-132,346 | $-74,272 | $-37,637 | $-45,256 |
| EPS Basic Total Ops | -27.30 | -36.70 | -25.70 | -15.10 | -20.70 |
| EPS Basic Continuous Ops | -27.29 | -36.74 | -25.67 | -15.09 | -20.71 |
| EPS Diluted Total Ops | -27.30 | -36.70 | -25.70 | -15.10 | -20.70 |
| EPS Diluted Continuous Ops | -27.29 | -36.74 | -25.67 | -15.09 | -20.71 |
| EBITDA(a) | $-110,634 | $-135,289 | $-78,183 | $-41,629 | $-46,742 |